Background: The aims of this study were to establish robust reference intervals and to investigate the factors influencing bone turnover markers (BTMs) in healthy premenopausal Spanish women. 
Introduction
Biochemical markers of bone turnover (BTMs) are used in the clinical setting for the initial assessment of osteoporosis, including the suspicion of secondary causes and the identification of patients with rapid bone loss, but particularly for monitoring the response to treatment [1] [2] [3] . For these reasons, it is essential to have robust reference ranges of BTMs, and it is very important to have a reliable upper limit as well as a low limit value for each marker. High BTM levels, particularly those of bone resorption, have been linked with a high fracture risk, and if levels are increased greatly, causes of high bone turnover other than osteoporosis, such as hyperparathyroidism, myeloma or thyrotoxicosis, should be ruled out [4, 5] . In addition, it has been considered that the goal of oral antiresorptive therapy was to reduce BTMs to within the lower half of the reference range interval for healthy premenopausal women [1] . With the post-marketing use of parenteral and more potent anti-resorptive drugs, such as zoledronic acid and denosumab [6, 7] , the lower limits of BTMs became more important than previously, as not only has it been questioned if decreases of BTMs below the reference interval could harm microdamage repair of the bone, but they also may be helpful in taking decisions in clinical practice, such as whether or not to give the next dose of a potent antiresorptive drug (e.g. zoledronic acid) [6] [7] [8] .
At present, in some countries such as in Spain, reference intervals must be fine-tuned, since they were performed years ago on a low number of individuals [9] , or were taken from the normalities of commercial brochures. In the last few years, reference intervals in premenopausal women from different countries in Europe (UK, France, Belgium and Denmark) [10, 11] and the US [11, 12] have been reported. In addition, data from Germany on men and women have been recently published [13] . In Spain, there are data on PINP and CTX-I in older men and in postmenopausal women [14] [15] [16] , as well as on CTX-I in a subset of 50 premenopausal women [17] . As our aim was to establish reliable BTM intervals, it was tempting to use the reference intervals for BTMs in premenopausal women from a country with a geographical proximity, such as France [11] . However, we could not assume that the environmental and lifestyle factors are the same in French and in Spanish women. In fact, we were further interested in comparing our data with those reported in other European countries in order to evaluate if premenopausal women from a Southern European setting have different or similar bone remodeling activity than those from Western, Northern or Central Europe. Therefore, and taking into consideration the importance of the pre-analytical variability when establishing the reference intervals, we designed this study involving a large cohort of healthy women born in Spain, with an age range of between 35 and 45. This age range was taken because BTM levels were considered to be stable by Glover et al. in their study assessing the reference interval in premenopausal British women [18] . In addition, other sources of variability were minimized, since the circadian rhythm and the influence of feeding are well known contributing factors in the pre-analytical variability of BTMs [1] . Furthermore, the seasons of the recruitment period, and consequently vitamin D levels were taken into account as possible sources of variability, even in a sunny country, such as Spain.
The aims of this study were to establish robust reference intervals for BTMs in healthy premenopausal Spanish women and to analyze the factors influencing their levels.
Materials and methods

Subjects
A total of 185 women from 35 to 45 years of age (mean: 40.2±3.1) from 13 medical centers in Catalonia (Northeast of Spain) were recruited as volunteers. Most of them were health workers and their friends. The study was carried out between February 10 and June 13, 2013. All women were healthy, non-pregnant and were regularly menstruating. All participants completed a questionnaire on medical and lifestyle factors, including height and weight, previous pregnancies, alcohol consumption, tobacco habit (current smokers), dairy products intake, physical exercise, drugs, including oral contraceptives (OCP), and any medical condition. We calculated the body mass index (BMI) as the weight (kg) divided by height (m) squared; alcohol consumption as standard drink units (ethanol content of 8-10 g) per day; dietary calcium intake, by the number of portions of dairy products multiplied by the milligrams of calcium per portion per day, and physical activity according to four categories: from inactivity to high intensity exercise. We excluded women with a recent pregnancy or fracture (within 12 months) or with a surgical procedure in the last 3 months, as well as women with any medical condition interfering with bone metabolism. Women on OCP and those with low vitamin D serum levels were included in the study. Ethical approval from each participating center was obtained as well as written informed consent from each participant in the study.
Biochemical and hormonal tests
Blood and second void urine samples were collected between 8 and 10 a.m. after an overnight fast in all individuals. Serum and urine samples were stored at −20 °C and plasma samples were stored at −80 °C until analysis. All the assays were performed by a central laboratory.
Serum bone alkaline phosphatase (bone ALP) was measured by ELISA (Immunodiagnostic Systems, Boldon, UK), with an analytical sensitivity of 0. 
Statistical analysis
A quantile regression was used to estimate the 5%, 50% and 95% percentiles and their 95%CI for the BMTs and to obtain unadjusted and OCP adjusted p-values. Standard non-parametric tests for [19, 20] . The Lin coefficient combines measures of both precision and accuracy to determine whether the observed data deviate significantly from the line of perfect concordance, which occurs at 45°, i.e. it assesses the linear relationship between two variables under the constraint where the intercept is zero and the slope is one. The value of Lin's coefficient increases as the accuracy and precision of the observed data improve [21] [22] [23] .
Results
In this study, 185 premenopausal women were recruited, and of these women we analyzed data from 184 (one subject was excluded because of unreliable outlier values in all BTMs). Their demographic characteristics are shown in Table 1 . Reference intervals for all BTMs (5%, 50% and 95% percentiles, as well as their 95% CI) obtained from the entire group of women and from the 164 women who were not on OCP are shown in Table 2 Table 3 ).
Discussion
This study provides robust reference intervals for BTMs in Spanish women and contributes to the identification of reference ranges for BTMs in Southern Europe. In addition, our results reinforce the effects of OCP and BMI on their levels, as OCP use was associated with lower levels of most bone formation markers and low BMI-induced higher levels of most BTMs. Interestingly, calcium intake influences serum CTX-I values.
It is of value to assess whether reference intervals for BTMs in premenopausal women differ according to the location of the country in Europe. This has been analyzed by Glover et al., comparing European data from UK, France and Belgium [11] . Surprisingly, Spanish values for bone ALP, PINP and serum CTX-I were quite similar to UKreported values, instead of those of French women from our neighboring country. Indeed, PINP and CTX-I, higher in France than in UK have been attributed to different lifestyle factors and BMI [11] . In addition, we found similar PINP and serum CTX-I values to those published by other authors in Italian and in German premenopausal women aged 35-45 years, particularly for total and intact PINP [13, 24] . However, these affirmations must be taken with caution as the compared studies were performed not only in different populations, but also under different analytical conditions. Thus, although all of them reported reference intervals for PINP and serum CTX-I using automated assays, samples were analyzed in different batches, and some of them in different laboratories. In addition, there were some discordant pre-analytical conditions. Most studies were performed in premenopausal women but the age ranges were not identical, and contrary to Glover et al. [18] , we have found that women from 35 to 40 have slightly higher BTM values ( < 15% in magnitude) than those between 40 and 45 years of age. In addition, most, but not all samples were collected between 8 a.m. and 10 a.m. Interestingly, Australian harmonized reference intervals for PINP and CTX-I in premenopausal women have been recently published, and the intervals are much wider. Indeed, the reference intervals for PINP [Roche] are 15-70 ng/mL in an age range of 25-49 years, with values of 15-90 ng/mL in women aged 20-24 years [25] . These results suggest that the reference intervals for PINP as well as for CTX-I, and probably for other BTMs, may be different when assessing a broad age range in the premenopausal population. Our reference intervals, established in a narrow age range (35-45 years), may be particularly useful in the assessment of response to antiresorptive therapy in postmenopausal osteoporosis [26] .
The International Osteoporosis Foundation (IOF) and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) recommended PINP and CTX-I as the reference BTMs in clinical studies [26, 27] . From our perspective, PINP is a very robust bone marker, as among all the analyzed factors possibly affecting BTMs, only BMI influenced its values after excluding OCP use. By contrast, CTX-I was influenced not only by age and BMI, but also by the dietary calcium intake and PTH values. This is in contrast with the findings of Eastell et al., who found that PTH levels did not affect CTX-I values, and bone ALP was the only BTM correlated with PTH [10] . Similar to our results, Michelsen et al. found an association between PTH and CTX-I [13] . The relationship between BTMs and 25OHD levels has received particular attention in most recent publications.
We found no difference in BTM levels when classifying individuals according to the median values or to tertiles, or according to levels higher or <50 nmol/L of 25OHD. Only OC showed different values in vitamin D-replete women when compared with those with vitamin D insufficiency or deficiency (25OHD < 75 and < 50 nmol/L, respectively).
However, the low number of vitamin-D replete individuals (n = 6) makes these differences of doubtful significance. Also, some authors have not found significant differences in BTMs when premenopausal women were classified in vitamin D deficient, insufficient or replete categories [18] . Yet other studies found a significant correlation between 25OHD levels and bone ALP [10, 11, 13] . It may be argued that 25OHD levels in our individuals were low, as the median value was 44.9 nmol/L, and more than 50% of them had 25OHD levels <50 nmol/L. Nonetheless, these are the values in healthy young women from our sunny country between February and June.
A relevant contribution of this study is the comparison of the two major automated assays used in Europe to perform PINP and CTX-I measurements. We found that there was a poor concordance and a clear trend with a negative slope for both analytes, and therefore, the interpretation of the bias could not be considered homogeneous along the observed values of CTX-I and PINP. The mean differences were more different from the null (zero differences) for larger values. Although the results were not homogeneous, median levels of PINP [Roche] were very similar to the median levels of intact PINP (PINP [IDS]) (36.0 and 36.6 μg/L, respectively), and we found higher median values for Elecsys CTX-I (CTX-I [Roche]) when compared with the IDS-ISYS assay (CTX-I [IDS]) (255 and 249 ng/L, respectively). Also, it has been pointed out that the major automated assays for measuring PINP provide harmonized results [28] . Although the reference intervals are similar, particularly when measuring PINP, our results support the fact that the obtained values are not interchangeable. As a consequence, the interpretation of PINP and CTX-I results and their reference intervals need to be established for each assay method, most importantly for CTX-I.
The strengths of this study are the homogeneous preanalytical and analytical conditions, such as a narrow age range of healthy women between 35 and 45 years of age, morning fasting samples between 8:00 and 10:00 a.m. and a central specialized laboratory, which decrease the degree of variability. The limitations of this study are the low number of individuals, the absence of bone mineral density data and the low values of 25OHD in a large proportion of the series. However, this fact reflects the vitamin D status in healthy young women in our country.
In conclusion, this study provides reference intervals of BTMs in healthy young women from a sunny Southern European country. Interestingly, BTM values are similar to those reported in UK, Germany and Italy, but different from Belgium and France, our neighbouring country. Taken together, it is recommended to establish reference intervals in each country, as a geographical neighbourhood does not imply exchangeable values for BTMs. Furthermore, reference intervals must be based on measurements with the same assay.
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